Free Trial
NASDAQ:TECX

Tectonic Therapeutic Q3 2024 Earnings Report

Tectonic Therapeutic logo
$22.31 +0.39 (+1.78%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$22.22 -0.09 (-0.40%)
As of 08/8/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Tectonic Therapeutic EPS Results

Actual EPS
-$1.20
Consensus EPS
-$0.84
Beat/Miss
Missed by -$0.36
One Year Ago EPS
N/A

Tectonic Therapeutic Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Tectonic Therapeutic Announcement Details

Quarter
Q3 2024
Time
After Market Closes
Conference Call Date
Wednesday, November 6, 2024
Conference Call Time
6:00PM ET

Upcoming Earnings

Tectonic Therapeutic's Q3 2025 earnings is scheduled for Wednesday, August 13, 2025

Tectonic Therapeutic Earnings Headlines

Tectonic (TECX) Q2 R&D Soars 142%
He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.
See More Tectonic Therapeutic Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Tectonic Therapeutic? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tectonic Therapeutic and other key companies, straight to your email.

About Tectonic Therapeutic

Tectonic Therapeutic (NASDAQ:TECX) engages in discovery and development of therapeutic proteins & antibodies. The company was founded by Timothy A. Springer and Andrew Kruse in 2019 and is headquartered in Watertown, MA.

View Tectonic Therapeutic Profile

More Earnings Resources from MarketBeat